Bolt Biotherapeutics, Inc. (BOLT) Executive Compensation
Bolt Biotherapeutics, Inc. (BOLT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BOLT
CIK: 1641281
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerIrene Baba
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-06 | 2026-10-01 | 8-K | 0001193125-26-415560 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-16 | 4 | 0001193125-26-396894 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-16 | 4 | 0001193125-26-396892 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-16 | 4 | 0001193125-26-396890 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-13 | — | SCHEDULE 13G Filing | 0001037389-26-000047 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344597 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344580 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267560 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267558 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267546 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267533 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-10 | 4 | 0001193125-26-267518 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-11 | 8-K | 0001193125-26-267487 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-219382 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001193125-26-219361 | View SEC Doc Filr Page |
| ARS | 2026-04-28 | 2025-12-31 | ARS | 0001193125-26-186950 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-28 | — | DEFA14A | 0001193125-26-186940 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-28 | 2026-04-27 | DEF 14A | 0001193125-26-186923 | View SEC Doc Filr Page |
| S-8 | 2026-03-12 | — | S-8 | 0001193125-26-104164 | View SEC Doc Filr Page |
| 10-K | 2026-03-12 | 2025-12-31 | 10-K | 0001193125-26-104121 | View SEC Doc Filr Page |
| 8-K | 2026-03-12 | 2026-03-12 | 8-K | 0001193125-26-104102 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-02-26 | — | SCHEDULE 13D/A Filing | 0001012975-26-000212 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-02-17 | — | SCHEDULE 13D/A Filing | 0001012975-26-000173 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0001213900-26-016669 | View SEC Doc Filr Page |
| 4 | 2026-02-04 | 2026-01-28 | 4 | 0001193125-26-037697 | View SEC Doc Filr Page |